Search Results for: rmat

UK should freeze mitochondrial replacement as Egli paper ID’s serious problem

Egli-genetic-drift-paper

An important new Cell Stem Cell paper from Dieter Egli’s lab points to an inherent, serious problem with so-called 3-person IVF or mitochondrial replacement technology that warrants putting an immediate hold on all efforts to use it in humans. I have pasted the graphical abstract from the paper below. For years a few of us scientists and […]

UK should freeze mitochondrial replacement as Egli paper ID’s serious problem Read More »

10 go-to stem cell & regenerative medicine websites of 2016

Top-10-websites

What are the top 10 stem cell websites? Where do you go to find the latest information and opinion on the stem cell and regenerative medicine fields? Today, that information flows almost from minute to minute via websites and from social media. This is a transformational difference from past decades when it would take months.

10 go-to stem cell & regenerative medicine websites of 2016 Read More »

FDA stem cell meeting now a 2-day public event in September

FDA-stem-cell-meeting

The FDA stem cell meeting that was supposed to take place in April is now officially going to be a 2-day event in September. This public meeting is meant to get comments on four draft guidances related to regs on stem cell products and treatments. FDA stem cell meeting From the FDA announcement on the meeting:

FDA stem cell meeting now a 2-day public event in September Read More »

Sweet 16 Science Twitter Accounts To Follow Innovative Medicine

STAT-logo

Below are 16 Science Twitter accounts that I think are musts to follow for those interested in transformative science and also medicine from a wide range of diverse, thought-provoking perspectives. I could list 160, but I’ve picked these 16 as a nice sampling with a lean towards those willing to take a risk in what

Sweet 16 Science Twitter Accounts To Follow Innovative Medicine Read More »

Alliance for Regenerative Medicine (ARM) Opposes REGROW Act, Risks to Patients Cited

Alliance-for-Regenerative-Medicine

The biggest debate today in the stem cell world is over how much regulation is needed for new, investigational stem cell therapies that are not as yet approved. Sometimes it feels very lonely being out there publicly advocating for appropriately thorough regulation of stem cell therapies and at times I get a lot of heat for

Alliance for Regenerative Medicine (ARM) Opposes REGROW Act, Risks to Patients Cited Read More »

Keys to successful stem cell translation – Nurses, physicians and patient advocates

Adrienne-Bell-Cors

Editor’s note: this is a guest post on stem cell translation. By Heather Main I recently attended the UCSD Health CIRM Alpha Stem Cell Clinics Network Symposium at the Sanford Consortium, San Diego. There was of course some great academic research presented, including conflicting views on liver stem cell compartments from Roel Nusse and David

Keys to successful stem cell translation – Nurses, physicians and patient advocates Read More »

Important, endangered species in stem cell medicine: the phase III trial

stem-cell-clinical-trial-system

Traditional clinical trials have four phases. Each phase plays an important, unique role in testing whether new drug products are safe and effective as well as how they compare to the standard of care. Today in the stem cell field across the globe, the Phase III is under fire including what some might call friendly

Important, endangered species in stem cell medicine: the phase III trial Read More »